Combining genome-wide association studies (GWAS) with metabolomics and Mendelian randomization is transforming precision medicine by uncovering causal links between genetic variants and clinical outcomes, rather than just correlations.
mGWAS – Integrating metabolomics in genome-wide association studies for more precise results
read more